MECHANISM FOR CHARGED-RELATED NEPHROTOXICITY
带电相关肾毒性的机制
基本信息
- 批准号:3243388
- 负责人:
- 金额:$ 11.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-01-01 至 1993-12-31
- 项目状态:已结题
- 来源:
- 关键词:angiotensin II antiport autoradiography calcium cations electron microscopy endocytosis gentamicins high density lipoproteins hydrogen isolation perfusion laboratory rabbit lysosomes magnesium membrane permeability membrane proteins membrane transport proteins protein transport renal toxin renal tubular transport sodium
项目摘要
Cationic substances like myeloma proteins, cationized albumin, and
gentamicin are nephrotoxic at the level of the proximal tubule. Transport
defects may occur rapidly, prior to the appearance of apparent biochemical
or morphological damage. An early defect is bicarbonaturia, which is due
to a reduction in Na/H antiporter activity in the luminal membrane of
proximal tubular cells. The toxic cationic substances mentioned above enter
the cells by endocytosis at the luminal membrane. We have recently shown
that endosomes containing cationic material fail to fuse with lysosomes
during early stages of uptake, and remain sequestered within the cytoplasm
of proximal tubular cells. This raises the possibility that membrane
transport proteins, including Na/H antiporters, may be taken up during the
endocytic process and become trapped in a pool of endosomes that are not
able to recycle normally. Preliminary evidence supports this
interpretation. Calcium and magnesium have been reported to protect against
gentamicin nephrotoxicity, and both inhibit binding of gentamicin to the
luminal membrane.
The purpose of this proposal is to examine the nature of early transport
defects in the kidney due to cationic substances. The following hypothesis
will be tested: endocytosis of cationic substances by renal proximal
tubular cells causes the internalization of plasmalemmal carriers, which
become trapped in a pool of cytoplasmic endosomes; calcium and magnesium
protect against these charge-related events. Thus, the following specific
aims are proposed: 1) to show that endocytosis of cationized albumin or
gentamicin by renal proximal tubular cells inhibits fusion of endosomes to
lysosomes, causing an accumulation of endosomal membrane in the cytoplasm
during the early phase of toxicity; 2) to show that endocytosis of
cationized albumin or gentamicin by renal proximal tubular cells results
in the internalization and sequestration of Na/H antiporters in a pool of
cytoplasmic endosomes, during the early phase of toxicity; 3) to show that
calcium and magnesium reduce endocytosis of cationized albumin and
gentamicin, diminish the endosomal-lysosomal fusion defect, and decrease
the sequestration of Na/H antiporters observed in renal proximal tubular
cells during the early phase of toxicity. The effects of cationized albumin
and gentamicin on membrane shuttling and Na/H antiporter activity will be
measured in microperfused proximal nephron segments and isolated renal
membranes.
阳离子物质,例如骨髓瘤蛋白,阳离子白蛋白和
庆大霉素在近端小管的水平上是肾毒性。运输
在出现明显的生化之前,可能会迅速发生缺陷
或形态损害。早期缺陷是碳尿酸,应得
减少Na/h抗胞菌活性在腔膜中的活性
近端管状细胞。上面提到的有毒阳离子物质进入
细胞通过腔膜的内吞作用。我们最近显示了
含有阳离子材料的内体无法与溶酶体融合
在摄取的早期阶段,并保持在细胞质中
近端管状细胞。这增加了膜的可能性
运输蛋白,包括Na/h抗植物,可以在此期间服用
内吞过程,被困在没有的内体中
能够正常回收。初步证据支持这一点
解释。据报道钙和镁可防止
庆大霉素肾毒性,都抑制庆大霉素与
腔膜。
该提议的目的是检查早期运输的性质
由于阳离子物质而导致的肾脏缺陷。以下假设
将测试:通过肾脏近端对阳离子物质的内吞作用
管状细胞引起浆膜载体的内在化,该载体的内在化
被困在细胞质内体的池中;钙和镁
防止这些与费用相关的事件。因此,以下特定
提出了目的:1)表明阳离子白蛋白的内吞作用或
肾近端管状细胞的庆大霉素抑制内体融合至
溶酶体,导致内体膜在细胞质中的积累
在毒性的早期; 2)表明内吞
肾脏近端管细胞的阳离子白蛋白或庆大霉素结果
在池中Na/h抗植物的内在化和隔离中
在毒性的早期阶段,细胞质内体; 3)表明
钙和镁降低阳离子白蛋白的内吞作用和
庆大霉素,减少内体 - 溶酶体融合缺陷,并减少
在肾近端肾小管中观察到的Na/H抗植物的隔离
毒性早期的细胞。阳离子白蛋白的影响
膜穿梭和Na/H抗胞菌活性的庆大霉素将是
在微源近端肾单位段和孤立的肾脏中测量
膜。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Darryl Peterson其他文献
Darryl Peterson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Darryl Peterson', 18)}}的其他基金
RENAL TRANSPORT AND HYDROLYSIS OF PEPTIDE HORMONES
肽激素的肾脏运输和水解
- 批准号:
3153038 - 财政年份:1983
- 资助金额:
$ 11.27万 - 项目类别:
CELLULAR PROCESSING OF GENTAMICIN IN PROXIMAL NEPHRON
庆大霉素在近端肾单位中的细胞加工
- 批准号:
3929234 - 财政年份:
- 资助金额:
$ 11.27万 - 项目类别:
CELLULAR PROCESSING OF GENTAMICIN IN THE PROXIMAL NEPHRON
庆大霉素在近端肾单位的细胞加工
- 批准号:
3908258 - 财政年份:
- 资助金额:
$ 11.27万 - 项目类别:
相似国自然基金
利用质体转基因技术研究开发高度耐盐的植物新品种
- 批准号:30571196
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
双转化耐盐日本光叶楮的培育
- 批准号:30471411
- 批准年份:2004
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
HUMAN PLACENTAL EPITHELIAL ION-COUPLED ANION TRANSPORT
人胎盘上皮离子耦合阴离子转运
- 批准号:
3331414 - 财政年份:1993
- 资助金额:
$ 11.27万 - 项目类别:
HUMAN PLACENTAL EPITHELIAL ION-COUPLED ANION TRANSPORT
人胎盘上皮离子耦合阴离子转运
- 批准号:
2202304 - 财政年份:1993
- 资助金额:
$ 11.27万 - 项目类别:
CELL GROWTH AND TRANSMEMBRANE SIGNALING BY AN INTEGRIN
整合素的细胞生长和跨膜信号传导
- 批准号:
3306663 - 财政年份:1991
- 资助金额:
$ 11.27万 - 项目类别: